Storia della carriera di Philip Roberts
Precedenti posizioni note di Philip Roberts
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMMUNOME, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2023 | 01/01/2024 |
| MIRATI THERAPEUTICS | Direttore Tecnico/Scientifico/R&S | 01/01/2019 | 01/11/2022 |
Formazione di Philip Roberts
| Louisiana State University | Graduate Degree |
| Rensselaer Polytechnic Institute | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Philip Roberts
- Esperienza
